Cargando…

Concurrent Hypofractionated Radiotherapy and 5-Fluorouracil for Advanced Sarcomas of the Bone

Purpose. 5-Fluorouracil (5-FU) has shown radiosensitizing properties in vitro. This paper reports the effects of radiotherapy and concomitant intravenous 5-FU radiosensitization in the treatment of advanced bone sarcomas. Subjects/methods. Four patients with large inoperable bone sarcomas (three cho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zambatis, Charalambos, Skarlatos, John, Koukourakis, Michael, Kosma, Lambrini, Giatromanolaki, Alexandra, Beroukas, Kostantinos, Yannakakis, Dimitrios
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395373/ https://www.ncbi.nlm.nih.gov/pubmed/18521229 http://dx.doi.org/10.1080/13577149878127

Ejemplares similares

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma
por: Koukourakis, M I, et al.
Publicado: (1999)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head–Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2022)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

The Feasibility Study of Hypofractionated Radiotherapy with Regional Hyperthermia in Soft Tissue Sarcomas
por: Spałek, Mateusz Jacek, et al.
Publicado: (2021)

Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma
por: Valle, Luca F., et al.
Publicado: (2021)

Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review
por: Roohani, Siyer, et al.
Publicado: (2022)

Ultra-Hypofractionated Re-Irradiation with Anti-PD-1 Immunotherapy for Locoregionally Recurrent (after Radical Chemo-Radiotherapy) Non-Small Cell Lung Cancer
por: Filippatos, Konstantinos, et al.
Publicado: (2023)

Cutaneous squamous-cell carcinoma of the head-neck area refractory to chemo-radiotherapy: benefit from anti-PD-1 immunotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme
por: Greer, Liana, et al.
Publicado: (2017)

Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma
por: Iwai, Takahiro, et al.
Publicado: (2020)

Could Concurrent Capecitabine with Hypofractionated Radiotherapy in Elderly Patients with Muscle-Invasive Bladder Cancer be an Option?
por: Youssief, Ayatallah A, et al.
Publicado: (2022)

Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients
por: Nanos, Christos, et al.
Publicado: (2022)

Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?
por: Koukourakis, M I, et al.
Publicado: (2003)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.
por: Koukourakis, M. I., et al.
Publicado: (1998)

Hypofractionated Preoperative Radiotherapy for High Risk Soft Tissue Sarcomas in a Geriatric Patient Population
por: Potkrajcic, Vlatko, et al.
Publicado: (2021)

Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation
por: Kalaitzis, Christos, et al.
Publicado: (2014)

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer
por: Conroy, T, et al.
Publicado: (2008)

Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy
por: Koukourakis, M I, et al.
Publicado: (2014)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Cost Minimization Analysis of Hypofractionated Radiotherapy
por: Yaremko, Hannah L., et al.
Publicado: (2021)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer
por: Koukourakis, Ioannis M., et al.
Publicado: (2023)

Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve
por: Koukourakis, Michael I, et al.
Publicado: (2016)

The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer
por: Giatromanolaki, Alexandra, et al.
Publicado: (2021)

p53 and angiogenesis in non-small-cell lung cancer.
por: Giatromanolaki, A., et al.
Publicado: (1998)

Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas
por: Kimura, Kana, et al.
Publicado: (2018)

Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide
por: Gregucci, Fabiana, et al.
Publicado: (2021)

Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk Wall
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2021)

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions
por: Boyce-Fappiano, David, et al.
Publicado: (2022)

Angiogenic Factor Expression in Hepatic Cirrhosis
por: Giatromanolaki, Alexandra, et al.
Publicado: (2007)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
por: Cho, L. Chinsoo, et al.
Publicado: (2013)

Image Fusion for Radiosurgery, Neurosurgery and Hypofractionated Radiotherapy
por: Inoue, Hiroshi K, et al.
Publicado: (2015)

Hypofractionated whole breast radiotherapy: current perspectives
por: Koulis, Theodora A, et al.
Publicado: (2015)

Hypofractionated radiotherapy to treat acne keloidalis nuchae
por: Kwan, Jennifer Yin Yee, et al.
Publicado: (2021)

Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection
por: Koukourakis, M I, et al.
Publicado: (2002)

Neoadjuvant Hypofractionated Radiotherapy and Chemotherapy in High-Grade Extremity Soft Tissue Sarcomas: Phase 2 Clinical Trial Protocol
por: Spencer, Ranyell MSB, et al.
Publicado: (2017)

Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
por: Koukourakis, Georgios V., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ug02frrucm687njf0cem9rr5qd